missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Filaggrin Antibody (FLG/1562), Novus Biologicals™
Mouse Monoclonal Antibody
Marque: Novus Biologicals NBP2-53245-100UG
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Filaggrin Monoclonal specifically detects Filaggrin in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.
Spécification
| Filaggrin | |
| Monoclonal | |
| 0.2 mg/mL | |
| Flow Cytometry 0.5 - 1 ug/million cells, Immunocytochemistry/Immunofluorescence 1 - 2 ug/ml, Immunohistochemistry-Paraffin 0.5 - 1.0 ug/ml, SDS-Page | |
| ATOD2, epidermal filaggrin, filaggrin, Profilaggrin | |
| Mouse | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| Filaggrin is an intermediate filament-associated protein that aggregates keratin intermediate filaments in mammalian epidermis. It is initially synthesized as a polyprotein precursor, profilaggrin (consisting of multiple filaggrin units of 324 aa each), which is localized in keratohyalin granules, and is subsequently proteolytically processed into individual functional filaggrin molecules. Active filaggrin is present at a level of the epidermis where keratinocytes are in transition between the live nucleated granular layer and the anucleate cornified layer, suggesting that filaggrin aids in the terminal differentiation process by facilitating apoptotic machinery. | |
| Store at 4C. | |
| IgG1 κ |
| Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), SDS-Page | |
| FLG/1562 | |
| Unconjugated | |
| 10mM PBS with 0.05% BSA with 0.05% Sodium Azide | |
| FLG | |
| Recombinant human Filaggrin protein fragment (aa 198-288) (exact sequence is proprietary) | |
| 100 μg | |
| Cytoskeleton Markers | |
| 2312 | |
| Human | |
| Purified |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
For Research Use Only
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu